New IV Ketamine for Depression Research Shows Promising Results

What the Newest Research Says About IV Ketamine for Depression

Written and reviewed by Nick Marino, Medical Director, Allay Health and Wellness

If you have lived with depression for a long time, you probably know the cycle. You try one medication, wait six weeks to see if it helps, and when it does not, you try another. Months pass. Sometimes years. For a lot of people that loop becomes its own kind of exhausting.

This is what doctors call treatment-resistant depression, and it is more common than most people think. Research suggests that roughly one in three people with depression still feel unwell after trying at least two different antidepressants. If that sounds like your story, you are not failing at treatment. The standard tools simply do not reach everyone. That is part of why a new wave of research on IV ketamine has drawn so much attention.

A Large New Study Pulled the Evidence Together

In 2026, a team of researchers from Harvard, Yale, and the University of Toronto published a review in JAMA Psychiatry, one of the most respected journals in the field. This kind of review does not run a brand new experiment. Instead it gathers every solid study on a question and looks at what they show together, which gives a much clearer picture than any single trial can.

The review combined 26 randomized controlled trials and more than 1,100 people who were going through a major depressive episode. Randomized controlled trials are considered the gold standard in medicine because they compare the treatment against a control group, which reduces the chance that a result is just luck or wishful thinking.

What the Research Found

Three findings stood out.

First, speed. A single ketamine infusion lowered depression symptoms within about four hours. Standard antidepressants often take four to six weeks to do anything at all. For someone in a dark place, the difference between four hours and four weeks is enormous. Second, the effect held. The improvement from one infusion lasted through the first week, which gives a person and their care team a real window to build on. Third, and maybe most important, ketamine reduced suicidal thoughts. In the studies that drop was meaningful, and for some people a measurable reduction in suicidal thinking was still present a full month after a single treatment.

The researchers also looked closely at safety. The most common side effects were headache, nausea, dizziness, and a temporary sense of feeling detached or dreamy during the session. These faded within hours. Serious problems were rare. The authors were clear that ketamine should only be given under medical supervision with proper screening and monitoring, which is exactly how it should work.

One more detail is worth knowing. Earlier research has found that the benefit can be even stronger in people who have already tried several medications without relief. In other words, the patients who often feel most stuck may be among those most likely to respond.

An Honest Word About Expectations

None of this means ketamine is a cure or that it works the same for everyone. It is not magic, and it is not the right fit for every person or every diagnosis. The research is genuinely promising, and it is also still growing. A single infusion opens a window, but lasting progress usually comes from a real plan, the right number of sessions for you, and steady support along the way. What the evidence does say is simple. For people who have not found relief through traditional treatment, IV ketamine is a serious, well-studied option that deserves a real conversation with a qualified provider.

Why Where You Go Matters

Because ketamine works on the brain and body quickly, the setting is not a small detail. IV ketamine should be given by trained medical staff who screen you first, watch over you during the session, and know exactly what to do if anything comes up. A calm, clinical environment is part of what makes the experience both safe and, for many people, genuinely restorative.

This is also where a good clinic earns its keep. Dosing, timing, how many sessions you need, how ketamine fits with the medications you already take, and what happens after each session are all clinical decisions that should be made with you, by people who do this every day.

How Allay Health and Wellness Can Help

At Allay Health and Wellness in Palm Beach Gardens, this is the work we do. We are an interventional psychiatry clinic, which means we focus on advanced treatments for people who have not gotten enough relief from standard care. Our team has spent more than eight years helping patients with depression, anxiety, and PTSD, and our medical director oversees every treatment plan personally.

A few things set the experience apart. We treat the whole picture, not a single infusion. Your plan is built around your history, your goals, and how you respond, with follow-up and support between sessions rather than a one-and-done appointment.

We offer more than one path. Alongside IV ketamine, we provide Spravato, a related medication FDA-approved for treatment-resistant depression, given as a nasal spray in our office. Spravato is often covered by insurance, which can make advanced treatment far more affordable for many people. During a consult we can walk through which option fits your situation and what coverage might look like for you.

And you are cared for by real clinicians in a real medical setting, with screening, monitoring, and a team that knows you by name.

Take the First Step

If you have been fighting depression and feel like you have run out of options, you have not. The science is moving, and there are treatments available today that did not exist a few years ago.

The first step is a conversation. Reach out to Allay Health and Wellness to schedule a consult, ask your questions, and find out whether IV ketamine or Spravato could be a fit for you. You deserve care that keeps up with the research.

This article is for general education and is not medical advice. IV ketamine for depression is an off-label use and is not FDA-approved for this indication. Spravato is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. Neither treatment is right for everyone and both require evaluation by a qualified medical provider. If you are in crisis or thinking about harming yourself, call or text 988 to reach the Suicide and Crisis Lifeline, or call 911.